MRPL4 Antibody

What is MRPL4 and what cellular roles has it been shown to play?

Genetic analyses in Drosophila have demonstrated that mRpL4 (the fly homolog) functions in Notch signal-receiving cells to permit target gene transcription during wing development . This regulatory function appears to be conserved across species, as knockout of mRpL4 in zebrafish also leads to downregulated expression of Notch signaling components . Importantly, human mRpL4 has been shown to functionally replace fly mRpL4 during wing development, suggesting evolutionary conservation of both its mitochondrial and non-mitochondrial functions .

In which tissues and subcellular compartments is MRPL4 predominantly expressed?

MRPL4 is primarily expressed in tissues with high energy demands, including the heart and skeletal muscle . This distribution pattern aligns with its canonical role in mitochondrial protein synthesis, as these tissues require substantial energy production through oxidative phosphorylation. Immunohistochemistry analyses using anti-MRPL4 antibodies have confirmed expression in human heart and thyroid tissues .

Regarding subcellular localization, while MRPL4 was traditionally thought to function exclusively within mitochondria, recent evidence indicates a more complex distribution pattern. When examined in Drosophila salivary gland cells, mRpL4 was detected in both cytoplasmic and nuclear compartments . This dual localization was confirmed through fractionation assays using wing disk cell lysates, which demonstrated the presence of endogenous mRpL4 protein in both cytoplasmic and nuclear fractions . This nuclear localization is particularly significant in light of mRpL4's role in regulating Notch signaling downstream of NICD (Notch Intracellular Domain) production .

What applications are MRPL4 antibodies validated for in research settings?

Anti-MRPL4 antibodies have been validated for several key research applications based on the provided information. The rabbit recombinant monoclonal MRPL4 antibody (clone EPR13151) has been specifically validated for:

• Western Blotting (WB): The antibody has been successfully used at a 1/1000 dilution to detect MRPL4 in various human cell lines including HeLa, HepG2, HL60, and HT29, producing bands at the predicted size of 35 kDa .

• Immunohistochemistry on Paraffin-embedded sections (IHC-P): The antibody functions effectively at a 1/50 dilution for detecting MRPL4 in paraffin-embedded human heart and thyroid tissues following heat-mediated antigen retrieval with citrate buffer (pH 6) .

• Human samples: The antibody has been validated specifically for reactivity with human samples .

While not explicitly mentioned in the search results, such antibodies are typically also used in immunofluorescence, immunoprecipitation, and ChIP assays when studying protein localization, interactions, and DNA binding properties.

What are the recommended protocols for optimizing Western blotting with MRPL4 antibodies?

When conducting Western blotting experiments with MRPL4 antibodies, researchers should consider the following optimized protocol based on validated approaches:

• Sample preparation:

  • Extract total protein from cells using standard lysis buffers containing protease inhibitors

  • Load approximately 10 μg of total protein per lane, as demonstrated in successful experiments with HeLa, HepG2, HL60, and HT29 cell lysates

• Antibody conditions:

  • Use anti-MRPL4 antibody at a 1/1000 dilution for optimal signal-to-noise ratio

  • Incubate with primary antibody at 4°C overnight with gentle rocking

• Detection:

  • Use ECL (Enhanced Chemiluminescence) technique for detection

  • Include positive controls from tissues with high MRPL4 expression (heart or skeletal muscle)

  • Expect a band at approximately 35 kDa, which is the predicted molecular weight for MRPL4

• Validation considerations:

  • Include samples from multiple cell lines to confirm antibody specificity

  • Consider including lysates from cells with MRPL4 knockdown as negative controls

  • For dual-function studies, consider nuclear and cytoplasmic fractionation to detect MRPL4 in different cellular compartments, as demonstrated in Drosophila studies

How should researchers optimize immunohistochemistry protocols with MRPL4 antibodies?

For optimal results when performing immunohistochemistry with MRPL4 antibodies, researchers should follow these validated procedures:

• Tissue preparation:

  • Use formalin-fixed, paraffin-embedded tissue sections

  • Cut sections at 4-6 μm thickness for optimal antibody penetration

• Antigen retrieval:

  • Perform heat-mediated antigen retrieval with citrate buffer at pH 6 before beginning the IHC staining protocol

  • This step is critical for unmasking epitopes that may be hidden due to fixation

• Antibody conditions:

  • Use the anti-MRPL4 antibody at a 1/50 dilution for optimal staining in human tissues

  • Incubate sections with primary antibody at 4°C overnight

• Controls and evaluation:

  • Include positive control tissues such as heart or thyroid, which have demonstrated reliable MRPL4 expression patterns

  • For studies investigating both mitochondrial and nuclear functions, evaluate subcellular localization patterns carefully

  • Consider dual staining with mitochondrial markers to distinguish canonical versus non-canonical localization

What experimental approaches can be used to study MRPL4's dual roles in mitochondrial and signaling functions?

Based on the successful research approaches documented, the following experimental strategies are recommended for investigating MRPL4's dual functions:

• Genetic manipulation approaches:

  • RNAi knockdown or CRISPR/Cas9 knockout of MRPL4 to assess both mitochondrial and signaling phenotypes

  • Rescue experiments with wild-type or mutant MRPL4 to determine functional domains responsible for each role

  • Cross-species rescue experiments to test evolutionary conservation (e.g., human MRPL4 in Drosophila systems)

• Protein interaction studies:

  • Immunoprecipitation to identify protein binding partners in different cellular compartments

  • For Notch signaling studies, examine interactions with pathway components such as wap and mnb, as demonstrated in Drosophila studies

  • Chromatin immunoprecipitation (ChIP) to assess binding to regulatory regions of Notch target genes

• Subcellular localization:

  • Cellular fractionation followed by Western blotting to quantify MRPL4 distribution between mitochondrial, cytoplasmic, and nuclear compartments

  • Immunofluorescence microscopy with co-staining for compartment-specific markers

  • Live-cell imaging with fluorescently tagged MRPL4 to track dynamic localization

• Functional readouts:

  • Mitochondrial function: Measure oxidative phosphorylation, ROS production, and ATP generation

  • Signaling function: Assess transcriptional outputs of Notch pathway using reporter constructs (e.g., NRE-GFP, Su(H)-LacZ)

  • Model organism phenotypes: Evaluate tissue-specific developmental outcomes (e.g., wing margin formation in Drosophila, zebrafish development)

What mechanisms underlie MRPL4's regulation of Notch signaling independent of its mitochondrial function?

The regulation of Notch signaling by MRPL4 appears to occur through mechanisms distinct from its canonical role in mitochondrial protein synthesis. Based on genetic and biochemical analyses, several key insights have emerged:

• Genetic positioning within the Notch pathway:

  • MRPL4 functions in Notch signal-receiving cells downstream of NICD production but upstream of target gene activation

  • In Drosophila wing development, mRpL4 mutant cells fail to respond to activated forms of Notch (NEXT and NICD), indicating a role in transcriptional regulation rather than receptor processing

  • Unlike knockdown of other mitochondrial ribosomal proteins (mRpS28 and mRpL24), specific knockdown of mRpL4 results in wing margin defects, suggesting a unique role beyond mitochondrial translation

• Molecular interactions:

  • mRpL4 physically and genetically interacts with the WD40 repeat protein wap

  • mRpL4 also interacts with the Ser/Thr protein kinase minibrain (mnb), which forms a heterodimer with wap

  • This wap-mnb complex is known to phosphorylate key signaling components during Drosophila wing development

  • Potential targets include specific residues in Su(H) and Notch that could be phosphorylated by the wap-mnb heterodimer

• Transcriptional regulation:

  • mRpL4 is required for proper Su(H) binding to enhancer regions of Notch target genes, as demonstrated by reduced Su(H) occupancy at regulatory regions of Enhancer of split Complex family genes, Cut, Wg, and Vestigial following mRpL4 knockdown

  • The proposed model suggests that mRpL4 interacts with the wap-mnb complex to regulate Su(H) activity, thereby modulating transcriptional output of Notch signaling

• Nuclear localization:

  • The nuclear presence of mRpL4 supports its direct role in transcriptional regulation

  • This dual localization distinguishes mRpL4 from most other mitochondrial ribosomal proteins and explains its ability to function in both mitochondrial and nuclear processes

How conserved is MRPL4's signaling function across species, and what experimental evidence supports this conservation?

The signaling role of MRPL4 demonstrates remarkable evolutionary conservation across species, supported by several lines of experimental evidence:

• Sequence conservation:

  • Amino acid sequence alignment reveals that mRpL4 is highly conserved from Drosophila to humans

  • This conservation suggests functional importance beyond mitochondrial protein synthesis

• Cross-species functional rescue:

  • Human mRpL4 protein can functionally replace Drosophila mRpL4 during wing development, rescuing both adult wing margin defects and downregulation of Cut expression in the wing disk when co-expressed with RNAi constructs targeting endogenous Drosophila mRpL4

  • Human mRpL4 also restores Wg expression and ROS production in mRpL4 mutant cells

  • These rescue experiments provide compelling evidence that the signaling function of MRPL4 is conserved across species

• Consistent phenotypes in different model organisms:

  • In Drosophila, mRpL4 regulates Notch signaling in multiple tissues, including wing development, larval neuroblasts, salivary gland imaginal rings, and adult midgut

  • Knockout of mRpL4 in zebrafish leads to decreased Notch signaling activity, suggesting a conserved regulatory role in vertebrates

• Molecular pathway conservation:

  • The Notch signaling pathway itself is highly conserved across metazoans

  • The functional interaction between mRpL4 and components like wap-mnb in regulating Notch signaling may represent an ancient regulatory mechanism that has been maintained throughout evolution

What methodological approaches are most effective for distinguishing between MRPL4's mitochondrial and signaling functions?

Distinguishing between MRPL4's dual roles requires carefully designed experimental approaches that can separate its mitochondrial functions from its signaling activities:

• Domain-specific mutational analysis:

  • Generate domain-specific mutations or truncations that selectively impair either mitochondrial or signaling functions

  • Test these constructs in rescue experiments to determine which domains are essential for each function

  • For example, mutations affecting mitochondrial targeting sequences versus regions involved in protein-protein interactions with signaling components

• Subcellular localization manipulation:

  • Create MRPL4 variants with altered localization signals to restrict the protein to specific cellular compartments

  • Add or remove nuclear localization signals or mitochondrial targeting sequences

  • Test whether compartment-restricted variants can rescue specific aspects of MRPL4 deficiency

• Comparative analysis with other MRPs:

  • Compare phenotypes of MRPL4 deficiency with those of other mitochondrial ribosomal proteins

  • As demonstrated in Drosophila, knockdown of mRpL4 but not mRpL24 or mRpS28 affected Notch signaling, indicating a specific role for mRpL4 beyond mitochondrial translation

  • This approach helps distinguish general effects of mitochondrial dysfunction from specific signaling roles

• Temporal separation of functions:

  • Use inducible expression systems to temporally control MRPL4 expression

  • Analyze immediate versus delayed effects to distinguish direct signaling roles from secondary consequences of mitochondrial dysfunction

  • Short-term effects are more likely to reflect direct signaling functions, while longer-term effects may involve both mechanisms

• Biochemical separation of complexes:

  • Use techniques such as blue native PAGE or sucrose gradient centrifugation to separate mitochondrial ribosome-associated MRPL4 from signaling complexes

  • Identify proteins uniquely associated with MRPL4 in non-mitochondrial contexts

  • Mass spectrometry analysis of these distinct complexes can reveal compartment-specific interaction partners

How do MRPL4 antibodies contribute to studying protein-protein interactions in Notch signaling regulation?

MRPL4 antibodies are valuable tools for investigating the protein-protein interactions that underlie its role in Notch signaling regulation:

• Co-immunoprecipitation studies:

  • MRPL4 antibodies can be used to pull down MRPL4 and its interacting partners from cell lysates

  • This approach has successfully identified interactions between mRpL4 and wap, as well as between mRpL4 and the Ser/Thr protein kinase minibrain (mnb) in Drosophila wing disk cell lysates

  • Similar studies have demonstrated interaction between Su(H) and wap

  • These findings support a model where mRpL4 interacts with the wap-mnb heterodimer to regulate Notch signaling

• Chromatin immunoprecipitation (ChIP) analysis:

  • Anti-MRPL4 antibodies can be used in ChIP experiments to determine whether MRPL4 directly associates with chromatin at Notch target gene loci

  • Previous studies have shown that mRpL4 knockdown decreases Su(H) occupancy at regulatory regions of Notch target genes

  • ChIP experiments with MRPL4 antibodies could establish whether MRPL4 is directly present in these transcriptional complexes

• Proximity-based labeling approaches:

  • Coupling MRPL4 antibodies with techniques such as BioID or APEX2 proximity labeling

  • These methods allow identification of proteins that are in close proximity to MRPL4 in different cellular compartments

  • This approach could reveal transient or context-specific interactions in the nucleus versus mitochondria

• Immunofluorescence co-localization:

  • Using MRPL4 antibodies in combination with antibodies against Notch pathway components

  • This approach can reveal spatial co-localization in specific subcellular compartments

  • Particularly valuable for examining nuclear co-localization with transcription factors like Su(H)

What are the emerging questions regarding MRPL4's role in cellular signaling beyond Notch?

The discovery of MRPL4's role in Notch signaling raises several important questions about its potential involvement in other signaling pathways:

• Are there additional signaling pathways regulated by MRPL4?

  • The dual localization of MRPL4 in both mitochondria and nucleus suggests it may participate in other nuclear signaling events

  • The interaction with wap-mnb, which can phosphorylate multiple targets, hints at broader regulatory roles

  • Future studies should investigate MRPL4's impact on other developmentally important pathways that interface with Notch signaling

• Does MRPL4 serve as a mediator between mitochondrial status and nuclear gene expression?

  • MRPL4 may function as a retrograde signaling factor, communicating mitochondrial status to the nucleus

  • This potential dual role could help coordinate energy metabolism with developmental signaling

  • Studies examining how mitochondrial stress affects MRPL4's nuclear translocation and activity could address this possibility

• What is the structural basis for MRPL4's dual functionality?

  • Structural studies of MRPL4 in different complexes (mitochondrial ribosome versus signaling complexes)

  • Identification of specific domains or post-translational modifications that regulate its participation in different cellular processes

  • Cryo-EM or X-ray crystallography of MRPL4 in complex with signaling partners could provide valuable insights

What technical challenges must be addressed to fully characterize MRPL4 antibodies for dual-function studies?

As research on MRPL4's dual functions advances, several technical challenges in antibody development and validation need to be addressed:

• Epitope-specific antibodies:

  • Development of antibodies targeting specific domains of MRPL4 involved in either mitochondrial or signaling functions

  • These would allow selective detection of MRPL4 engaged in different cellular processes

  • Validation of these antibodies would require testing in cells expressing domain-specific MRPL4 mutants

• Post-translational modification-specific antibodies:

  • If MRPL4's dual functions are regulated by post-translational modifications, antibodies specifically recognizing these modifications would be valuable

  • Such antibodies could help determine how MRPL4's activities are switched between mitochondrial and signaling roles

  • Mass spectrometry analysis would first be needed to identify relevant modifications

• Species-specific validation:

  • While human MRPL4 can functionally replace Drosophila mRpL4, antibodies may have different specificities across species

  • Careful validation of cross-reactivity is needed for comparative studies

  • The high conservation of MRPL4 across species suggests antibodies might cross-react, but this requires experimental confirmation

• Context-dependent confirmation:

  • Antibodies should be validated in contexts where MRPL4 is known to be involved in signaling versus mitochondrial functions

  • This would ensure that the antibody can reliably detect MRPL4 in different functional states and protein complexes

  • Sequential immunoprecipitation or fractionation followed by immunoblotting could help establish this specificity